Evidence map›Paper›PMID 41818151›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Control of microglial dynamics by the Arp2/3 complex and the autism- and schizophrenia-associated protein CYFIP1.

James Scott-Solache, Jiaxin Pei, James Drew, Guillermo López-Doménech, Renaud B Jolivet, Manuela Nieto-Rostro, Elizabeth C Davenport, I Lorena Arancibia-Cárcamo, David Attwell, Josef T Kittler

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. ImpairedNature communications · 2026
    Article
  4. Article
  5. The Arp2/3 complex is required forbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

James Scott-Solache *Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.ORCID 0009-0007-2935-3060
Jiaxin Pei *Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
James Drew *Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
Guillermo López-DoménechDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
Renaud B JolivetDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-5167-0851
Manuela Nieto-RostroDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
Elizabeth C DavenportDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-4652-0234
I Lorena Arancibia-CárcamoDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.
David AttwellDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0003-3618-0843
Josef T KittlerDepartment of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-3437-9456

Funding

Wellcome Trust 099222Wellcome Trust 219366Wellcome Trust (WT) 223202/Z/21/ZWellcome Trust (WT) 22519/Z/21/Z
6 · The paper itself

Abstract

Microglia use a highly complex and dynamic network of branched processes to sense and respond to their surroundings. Despite emerging evidence that microglial motility plays important roles in brain development, neurodegeneration, and neuropsychiatric disease, little is known about the intracellular machinery orchestrating microglial process dynamics. Here, we identify roles for regulators of the actin cytoskeleton in controlling microglial behavior. We show that the actin branching Arp2/3 complex is critical for maintaining microglial morphology and is required for surveillance but not chemotactic motility. Neuropsychiatric disease-associated CYFIP1, a core component of the WAVE regulatory complex linking upstream signaling pathways to activation of the Arp2/3 complex, is highly expressed in microglia but has an unknown function. We report that conditional deletion of

Indexed as

Actin-Related Protein 2-3 ComplexAdaptor Proteins, Signal TransducingMicrogliaAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticBrainCD68 MoleculeChemotaxisHumansMiceMice, KnockoutPhagocytosisActin-Related Protein 2-3 ComplexAdaptor Proteins, Signal TransducingAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCyfip1 protein, mouse15q11.2glianeuroinflammationphagocytosisWRC

Identifiers

PMID41818151
PMCPMC12993954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.